TCTR20260723002进行中（未招募）4 期
Medication Adherence Among Patients With Heart Failure Using an Electronic Health Monitoring Application at Hanoi Heart Hospital
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- Self-funded
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Adults aged 18 years or older.
- •Diagnosed with heart failure with left ventricular ejection fraction below 50 percent confirmed by echocardiography.
- •Hospitalized for acute heart failure and discharged in stable condition.
- •Receiving guideline-directed medical therapy for heart failure.
- •Own and are able to use a smartphone and the electronic health monitoring application.
- •Able to communicate and complete study questionnaires.
- •Provide written informed consent.
排除标准
- •Severe cognitive impairment, psychiatric disorders, impaired consciousness, or other conditions that prevent reliable communication or completion of study procedures.
- •Severe hearing or visual impairment that prevents use of the electronic health monitoring application.
- •Terminal illness or other severe comorbidities with an expected life expectancy of less than six months.
- •End-stage renal disease requiring dialysis or other serious medical conditions that would interfere with study participation or follow-up.
- •Inability or unwillingness to use a smartphone or the electronic health monitoring application.
- •Refusal or inability to provide written informed consent.
研究组 & 干预措施
Participants will receive a six-month electronic health monitoring program beginning before hospital discharge. The program includes individualized health education, medication reminders, follow-up appointment reminders, educational materials, symptom monitoring, and continuous remote support through an electronic health monitoring application. Monthly follow-up and ongoing communication with healthcare professionals will be provided throughout the intervention period. The intervention aims to improve medication adherence and self-management among patients with heart failure after hospitalization.;Experimental Behavioral;Electronic Health Monitoring Program for Patients with Heart Failure
干预措施: Participants will receive a six-month electronic health monitoring program beginning before hospital discharge. The program includes individualized health education, medication reminders, follow-up appointment reminders, educational materials, symptom monitoring, and continuous remote support through an electronic health monitoring application. Monthly follow-up and ongoing communication with healthcare professionals will be provided throughout the intervention period. The intervention aims to improve medication adherence and self-management among patients with heart failure after hospitalization.;Experimental Behavioral;Electronic Health Monitoring Program for Patients with Heart Failure
研究者
相似试验
招募中
不适用
Optimizing Heart Failure Therapies Among Patients With Limited Access in DenverHeart FailureMedication OptimizationNCT07435662Denver Health and Hospital Authority40
招募中
Unknown
冠心病患者出院后用药依从性相关文献研究及影响因素分析冠心病ChiCTR2400081346
招募中
不适用
Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)Heart Failure and Reduced Ejection FractionHeart FailureNCT07701876Ruijin Hospital Luwan Branch1,740
进行中（未招募）
不适用
Association of Heart Failure Aggravation and Device-based Sensor ParametersCardiomyopathyHeart FailureNCT07753135Samsung Medical Center500
尚未招募
4 期
A clinical trial to check the effectiveness and safety of brand sacubitril and Valsartan along with generic sacubitril and valsartan in patients of Heart failure.Systolic (congestive) heart failure,CTRI/2024/09/074204Dr Sandarbh Patel12